Insulin requirement after one year of insulin therapy in type 2 diabetic patients dependent on fasting C-peptide

Netherlands Journal of Medicine

Volumn 66, Issue 6, 2008, Pages 259-260

  Biesenbach, George ^a   Bodlaj, G ^a   Pieringer, H ^a   Raml, A ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA;

BODY WEIGHT; DIET RESTRICTION; DRUG TREATMENT FAILURE; GLUCOSE BLOOD LEVEL; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; TREATMENT DURATION; WEIGHT GAIN;

C-PEPTIDE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PROGNOSIS;

EID: 46649085077     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Keller U, Pasquel M, Berger W. C-peptide determination in diabetics for the evaluation of insulin requirement. Schweiz Med Wschr 1987;117:187-92.
2. Lee A, Morley. Classification of-type 2 diabetes by clinical response to metformin-troglitazone combination and C-peptide criteria. Endoc Pract 1999;5:305-13.
3. Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, Menheere PP. Prognostic factors for successful insulin therapy in subjects with type 2 diabetes. Neth J Med 1999;54:63.9.
4. Relimpio F, Losada F, Pumar A, et al. Relationships of C-peptide levels and the C-peptide/blood sugar ratio with clinical/biochemical variables associated with insulin resistance in orally-treated, well-controlled type 2 diabetic patients. Diabetes Res Clin Pract 1997;36:173-80.
5. Grant PJ, Barlow E, Milles DW. Plasma C-peptide levels identify insulin-treated diabetic patients suitable for oral hypoglycaemic therapy. Diabet Med 1984;1:284-6.
6. Rigalleau V, Baillet-Blanco L, Perlemoine C, Salmi LR, Gin H. Lower plasma triglycerides are associated with increased need for insulin requirement in poorly controlled type 2 diabetic patients. Diabet Med 2005;22:877-81.